132 related articles for article (PubMed ID: 31468429)
1. Anti-Cancer Mechanisms of Taurine in Human Nasopharyngeal Carcinoma Cells.
He F; Ma N; Midorikawa K; Hiraku Y; Oikawa S; Mo Y; Zhang Z; Takeuchi K; Murata M
Adv Exp Med Biol; 2019; 1155():533-541. PubMed ID: 31468429
[TBL] [Abstract][Full Text] [Related]
2. Taurine exhibits an apoptosis-inducing effect on human nasopharyngeal carcinoma cells through PTEN/Akt pathways in vitro.
He F; Ma N; Midorikawa K; Hiraku Y; Oikawa S; Zhang Z; Huang G; Takeuchi K; Murata M
Amino Acids; 2018 Dec; 50(12):1749-1758. PubMed ID: 30225664
[TBL] [Abstract][Full Text] [Related]
3. Taurine induces upregulation of p53 and Beclin1 and has antitumor effect in human nasopharyngeal carcinoma cells in vitro and in vivo.
Okano M; He F; Ma N; Kobayashi H; Oikawa S; Nishimura K; Tawara I; Murata M
Acta Histochem; 2023 Jan; 125(1):151978. PubMed ID: 36470150
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
5. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
6. Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment.
Yee-Lin V; Pooi-Fong W; Soo-Beng AK
Mini Rev Med Chem; 2018; 18(2):173-183. PubMed ID: 28714398
[TBL] [Abstract][Full Text] [Related]
7. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
8. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
Huang S; Li X; Zhu H
Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived tumor models for human nasopharyngeal carcinoma.
Zhou X; Zhao W; Chen Y; Zhang Z
Enzymes; 2019; 46():81-96. PubMed ID: 31727278
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
11. Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity.
Voon YL; Ahmad M; Wong PF; Husaini R; Ng WT; Leong CO; Lane DP; Khoo AS
Oncol Rep; 2015 Oct; 34(4):1692-700. PubMed ID: 26252575
[TBL] [Abstract][Full Text] [Related]
12. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
13. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
14. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
[TBL] [Abstract][Full Text] [Related]
16. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
[TBL] [Abstract][Full Text] [Related]
17. 14-Thienyl methylene matrine (YYJ18), the derivative from matrine, induces apoptosis of human nasopharyngeal carcinoma cells by targeting MAPK and PI3K/Akt pathways in vitro.
Xie M; Yi X; Wang R; Wang L; He G; Zhu M; Qi C; Liu Y; Ye Y; Tan S; Tang A
Cell Physiol Biochem; 2014; 33(5):1475-83. PubMed ID: 24854624
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor.
Liu F; Wang L; Yi S; Liu Q; Xu X; Su M
Biomed Pharmacother; 2019 Dec; 120():109533. PubMed ID: 31634779
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Activity Evaluation of Nasopharyngeal Carcinoma Inhibitors Based on 6-(Pyrimidin-4-yl)-1H-indazole.
Liao B; Peng L; Zhou J; Mo H; Zhao J; Yang Z; Guo X; Zhang P; Zhang X; Zhu Z
Chem Biodivers; 2019 May; 16(5):e1800598. PubMed ID: 30788913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
